Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-006529

Chairman and CEO bought 7,500 shares at an average $1.16 ($8,725)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Chairman and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-15 Purchase : show line 1 in the form +2,500 $1.17 $2,925 37,500 D
2017-06-15 Purchase : show line 2 in the form +5,000 $1.16 $5,800 42,500 D
Open-market purchases · 7,500 sh · avg $1.16 · $8,725
Loading xslF345X03/f4061517seth_actinium.xml…